Screening device detecting lung cancer biomarkers shows promise for early lung cancer detection
Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...
Xilio reports results from ongoing Phase 2 clinical trial of vilastobart
Xilio Therapeutics (XLO) announced initial data from its ongoing Phase 2 clinical trial evaluating vilastobart, or XTX101, a tumor-activated, ...
verywellhealth15d
The 5 Types of Antibodies
Each antibody produced by your immune system binds to a specific antigen and then either destroys the pathogen or tags it so other immune cells will recognize it. Antibodies are also known as ...
ascopubs.org23d
Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial Colorectal cancer (CRC) remains a major global ...
Frontiers27d
CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment
Other markers, such as protein induced by carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA), and carbohydrate antigen 125(CA125), have attracted attention for their diagnostic and ...
Frontiers1mon
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
In 2023, a new phase I trial (NCT05745454) began to recruit patients with HER2 positive solid tumors. Carcinoembryonic Antigen (CEA) is an established tumor marker in epithelial solid tumors including ...